MLKL and cancer: Understanding the complex contributions of RIP1-RIP3 and MLKL in human disease is important, as necroptotic cell death has been associated with more than 30 human diseases (52), including cancer (53) and more than 20 approved drugs have the potential to regulate necroptosis (52).